A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.
about
Model for End-stage Liver DiseaseComparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting listSpontaneous evolution in bilirubin levels predicts liver-related mortality in patients with alcoholic hepatitis.Prognostic Significance of the Systemic Inflammatory and Immune Balance in Alcoholic Liver Disease with a Focus on Gender-Related DifferencesSarcopenia in the prognosis of cirrhosis: Going beyond the MELD score.Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.Development of organ-specific donor risk indices.Liver volume in the cirrhotic patient: does size matter?Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List PatientsLiver transplantation: Advances and perioperative care.Model for end-stage liver disease: end of the first decade.Kidney, pancreas and liver allocation and distribution in the United StatesModerate hyperkalemia in hospitalized patients with cirrhotic ascites indicates a poor prognosis.Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future Directions in Canada.The model for end-stage liver disease score-based system predicts short term mortality better than the current Child-Turcotte-Pugh score-based allocation system during waiting for deceased liver transplantationChanging pattern of donor selection criteria in deceased donor liver transplant: a review of literature.Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine.The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascites.Acute-on-chronic liver failure in chronic hepatitis B.Important predictor of mortality in patients with end-stage liver disease.Model for end-stage liver disease score and MELD exceptions: 15 years later.The donor risk index: A decade of experience.Overview of Staging Systems for Hepatocellular Carcinoma and Implications for Interventional Radiology.Performance of Disease-Specific Scoring Models in Intensive Care Patients with Severe Liver Diseases.Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma.Variant outcomes of liver transplantation for hepatitis C virus patients in different age categories: impact of the model for end-stage liver disease score.The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.Implications of Hyponatremia in Liver TransplantationThe evolution in the prioritization for liver transplantation.Predictive value of Refit Model for End-Stage Liver Disease, Refit Model for End-Stage Liver Disease-Na, and pre-existing scoring system for 3-month mortality in Korean patients with cirrhosis.
P2860
Q26864971-157272B4-713C-4B87-B8E5-FDE76F6C596BQ28731277-0073DBCB-2A33-415F-842C-D3A5A126E76DQ33889762-58BCAA8B-0048-40DB-A392-F88E0542DE26Q35673289-01754ED0-473A-4D70-88AC-ADC99E78858AQ35819511-74DE5E59-D2A1-4436-8F5E-DF0BB8CE01DAQ35869964-33C0B646-658B-4E11-88A2-8864021120CFQ35903771-2DADA675-78E3-4134-998D-74F0481440C9Q36047321-F1168A95-F820-4A85-8D92-50CFCBDD17E0Q36262430-61BE7037-88D8-4591-95BB-8EF0245BB603Q36313395-B3888929-D261-435D-9838-52D5F341EABFQ36588122-B84B3B4F-4FFF-4821-8AB7-9A9845A514BAQ36591435-AB86AB7F-07FF-4E4F-9E73-092F9770E7D6Q36634933-A95A5D14-7D16-457F-87CA-837202CC382FQ36997090-1D3DEAF6-DC90-41E4-92EC-62F06A3CC228Q37098099-2E57C0F9-8D57-4814-8E8F-9C67A751A70DQ37613628-8CE495E1-549A-4A51-AB66-CC553B0D4876Q37636499-5D035729-F1A2-4741-852A-D75FBD47008AQ37711322-1A559442-0899-47D2-8260-21F57D80BCDEQ37958079-51547ADB-414B-463E-A911-9F2DB54A751DQ38120248-36B24784-B00C-4A1D-AACF-9BC1A9E5C664Q38504284-133226BF-A2A6-4AD4-B4E4-07797ACDA86AQ38738555-EF5D4110-DE66-4260-9B70-15BE934F1CA1Q39349696-14BBEF4F-7FD5-4377-83A9-21C74A0C5210Q40099318-C6E73BD4-D3B4-4E1E-95CB-6741FDF06059Q40329199-0E56DA81-29C5-4754-9DF9-8A57B24282E4Q40363980-4C235484-6BB4-42F0-B217-F2970581DDC1Q40945206-BD6C3FC3-ABA6-4A9E-BD37-8A24B5413369Q42087113-80EAB019-7977-41BD-B64C-C31A0479F924Q42406771-334B5842-DE73-4BC4-84FC-7F65EECAD66AQ50870578-5D96460C-22F3-457B-8A6B-25280093F21B
P2860
A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A revised model for end-stage ...... waiting liver transplantation.
@ast
A revised model for end-stage ...... waiting liver transplantation.
@en
type
label
A revised model for end-stage ...... waiting liver transplantation.
@ast
A revised model for end-stage ...... waiting liver transplantation.
@en
prefLabel
A revised model for end-stage ...... waiting liver transplantation.
@ast
A revised model for end-stage ...... waiting liver transplantation.
@en
P2093
P2860
P1433
P1476
A revised model for end-stage ...... waiting liver transplantation.
@en
P2093
Joanne T Benson
Joseph J Larson
Michael D Leise
Terry M Therneau
Walter K Kremers
P2860
P304
P356
10.1053/J.GASTRO.2011.02.017
P407
P577
2011-02-18T00:00:00Z